Kevin Weinstein

CEO

Renalogic

Jul 2021 - Current (5 years)

President

Azara Healthcare

Dec 2020 - Jul 2021 (8 months)

- Drove SPH Ignite merger with Azara Healthcare - Subsequently led all company commercial efforts

CEO of SPH Ignite, Inc.

SPH Analytics

Mar 2020 - Dec 2020 (10 months)

- Hired as CEO of SPH Ignite, Inc., the Population Health subsidiary of SPH Analytics, which had separate Board of Directors and investors - Turned company EBITDA positive, attracted outside investor and led all phases of complex transaction to merge with Azara Healthcare

Board Member

Strata Health Canada a VitalHub Company

Jan 2019 - Oct 2024 (5 years 10 months)

Strata was acquired by Canadian healthcare software company VitalHub (TSX: VHI) in October 2024.

Advisor

Prefix Health Technologies

Oct 2018 - Jun 2020 (1 year 9 months)

Board Member

Fibroblast Acquired by Cerner Corporation

Jun 2018 - Nov 2020 (2 years 6 months)

Acquired by Cerner Nov 2020.

CEO

Analyte Health

May 2017 - Aug 2018 (1 year 4 months)

Hired to turn-around this pioneering direct-to-consumer diagnostic testing company. Stabilized the business, turning a prior year 20% decline in revenue to 12% revenue growth, launched a new brand on a completely new technology stack, with more than 20 new product SKUs, and renegotiated supplier and partner contracts. Successfully sold the company in August 2018.

Chief Growth Officer

Valence Health now Evolent Health

Oct 2012 - Dec 2016 (4 years 3 months)

Responsible for Marketing, Sales, Business Development, and Corporate Development building these departments and teams from scratch following a series A investment. Grew revenues from less than $30 million to more than $140 million in 4 years. Supported sale of company to Evolent (NYSE: EVH) in Q4 2016.

Vice President of Marketing and Sales Operations

ZirMed now part of Waystar

Aug 2010 - Oct 2012 (2 years 3 months)

Recruited shortly after Sequoia invested in the company. Established Marketing function and team from scratch, with a focus on product marketing, lead generation and sales education/support. Helped drive ~20% annual growth and entry into Enterprise market. ZirMed was eventually sold to Bain Capital for ~$750 million.

Chief Growth Officer

Rise Health Inc

Jun 2009 - Oct 2010 (1 year 5 months)

Part of founding team for this early value-based services company. Supported initial fundraising, product conceptualization, and early customer pilots. Rise Health was eventually sold to Best Doctors, who in turn was sold to Teladoc (NYSE: TDOC).

Vice President of Marketing and Sales Operations

Allscripts

Apr 2005 - Jul 2009 (4 years 4 months)

Oversaw marketing for the company's largest business unit, and subsequently created the Sales Operation function for the entire company from scratch. Supported organic growth of >40% within Business Unit and oversaw $30 million P&L and team of 30+, including technology hardware engineers, clinical sales experts, inside sales, marketing, and sales operations.

K

Principal

Kettle Partners

Aug 2000 - Aug 2003 (3 years 1 month)

Technology-focused venture capital firm with $85M under management and 15 portfolio investments. Responsible for due dillengce, investment process, and portfolio company consulting.

Associate

Oliver Wyman

Jan 1999 - Dec 2000 (2 years)

Chief Executive Officer

Renalogic

About

Detail

Timeline

Résumé